In terms of valuation, Mira Pharmaceuticals Inc’s market capitalization stands at $15.52 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s ...
MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a preclinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...
Investment analysts at Rodman & Renshaw began coverage on shares of MIRA Pharmaceuticals (NASDAQ:MIRA – Get Free Report) in a research report issued to clients and investors on Monday ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...